US Patent Issued to ARNATAR THERAPEUTICS on March 31 for "Translation enhancing nucleic acid compounds: ASO coupled translation-upregulation 1 (ACT-UP1) and uses thereof" (California Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,307, issued on March 31, was assigned to ARNATAR THERAPEUTICS INC (San Diego).

"Translation enhancing nucleic acid compounds: ASO coupled translation-upregulation 1 (ACT-UP1) and uses thereof" was invented by Xuehai Liang (San Diego) and Lingdi Zhang (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and compounds for enhancing gene expression by ACT-UP1 compounds. Such methods and compounds are useful for increasing expression of certain genes, many of which are associated with a variety of diseases and disorders."

The patent was filed on Feb. 14, 2025, under Application No. 19/054,728.

*For further informatio...